Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Return on Sales (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Return on Sales for 6 consecutive years, with 7.85% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 2590.0% to 7.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 17.95% through Dec 2025, up 1579.0% year-over-year, with the annual reading at 17.96% for FY2025, 1579.0% up from the prior year.
  • Return on Sales for Q4 2025 was 7.85% at Relay Therapeutics, up from 35.52% in the prior quarter.
  • The five-year high for Return on Sales was 83496.0% in Q4 2023, with the low at 827.66% in Q2 2023.
  • Average Return on Sales over 5 years is 4032.65%, with a median of 67.83% recorded in 2021.
  • The sharpest move saw Return on Sales soared 8376272bps in 2023, then crashed -8352975bps in 2024.
  • Over 5 years, Return on Sales stood at 118.97% in 2021, then plummeted by -124bps to 266.72% in 2022, then skyrocketed by 31405bps to 83496.0% in 2023, then tumbled by -100bps to 33.75% in 2024, then surged by 77bps to 7.85% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 7.85%, 35.52%, and 103.02% for Q4 2025, Q3 2025, and Q2 2025 respectively.